The RBPJ/DAPK3/UBE3A signaling axis induces PBRM1 degradation to modulate the sensitivity of renal cell carcinoma to CDK4/6 inhibitors. The gene discussed is RBPJ; the disease is hereditary clear cell renal cell carcinoma.